Suppr超能文献

[现代氟喹诺酮类药物对鼻疽杆菌体内实验疗效的研究]

[Study of efficacy of modern fluoroquinolones against agent of glanders in experiments in vivo].

作者信息

Bondareva T A, Borisevich I V, Kalininskiĭ V B, Bondarev V P, Fomenkov O O

出版信息

Zh Mikrobiol Epidemiol Immunobiol. 2009 May-Jun(3):10-3.

Abstract

AIM

Efficacy of modern fluoroquinolones for urgent prophylaxis and treatment of experimental glanders was studied. In experiments on laboratory animals in vivo, it was shown that sparfloxacin, gemifloxacin, levofloxacin and moxifloxacin were highly effective for urgent prophylaxis and treatment of glanders.

MATERIALS AND METHODS

Golden hamsters of both sexes, with weight 80 - 100 g, were inoculated with 100 LD50 of 48-hour agar culture of Burkholderia mallei (strain ts-5). Commercial preparations of 2 - 4th generations of fluoroquinolones: sparfloxacin (Sparflo, India), gemifloxacin (Faktiv, Russia), moxifloxacin (Avelox, Germany), pefloxacin (Abactal, Slovenia), levofloxacin (Eleflox, India), lomefloxacin (Lomeflox, India), ofloxacin (Russia). Urgent prophylaxis started 3 hours after inoculation with duration of 10 days, whereas treatment started 24 hours after inoculation with duration of 15 days. Daily dose of pefloxacin, ciprofloxacin, of loxacin was divided on 2 parts, which were administered with 12-hour interval; other drugswere administered once a day.

RESULTS

All studied drugs, excluding lomefloxacin, were highly effective for urgent prophylaxis and treatment of experimental glanders and provided 80 - 100% protection.

CONCLUSION

Third-fourth generations of fluoroquinolones: sparfloxacin, levofloxacin, moxifloxacin, gemifloxacin were highly effective against agent of glanders in in vivo experiments. They are promising drugs for the development of schemes for urgent prophylaxis and treatment of glanders in humans.

摘要

目的

研究现代氟喹诺酮类药物对实验性鼻疽进行紧急预防和治疗的效果。在体内对实验动物进行的实验表明,司帕沙星、吉米沙星、左氧氟沙星和莫西沙星对鼻疽的紧急预防和治疗非常有效。

材料与方法

选用体重80 - 100克的雌雄金黄仓鼠,接种100 LD50的48小时鼻疽伯克霍尔德菌(ts-5菌株)琼脂培养物。2 - 4代氟喹诺酮类药物的市售制剂:司帕沙星(印度,Sparflo)、吉米沙星(俄罗斯,Faktiv)、莫西沙星(德国,Avelox)、培氟沙星(斯洛文尼亚,Abactal)、左氧氟沙星(印度,Eleflox)、洛美沙星(印度,Lomeflox)、氧氟沙星(俄罗斯)。紧急预防在接种后3小时开始,持续10天,而治疗在接种后24小时开始,持续15天。培氟沙星、环丙沙星、洛美沙星的每日剂量分为两部分,间隔12小时给药;其他药物每天给药一次。

结果

除洛美沙星外,所有研究药物对实验性鼻疽的紧急预防和治疗都非常有效,提供了80 - 100%的保护。

结论

第三代和第四代氟喹诺酮类药物:司帕沙星、左氧氟沙星、莫西沙星、吉米沙星在体内实验中对鼻疽病原体非常有效。它们是开发人类鼻疽紧急预防和治疗方案的有前景的药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验